GSE209698 calcitriol D 2 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE209698_calcitriol_D_2_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE209698_calcitriol_D_2_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE209698_calcitriol_D_2_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE209698_calcitriol_D_2_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 4

Gene

long intergenic non-protein coding RNA 205

Gene

small nucleolar RNA host gene 12

Gene

USP2 antisense RNA 1

Gene

dual specificity phosphatase 13A

Gene

ZBED5 antisense RNA 1

Gene

RRN3 pseudogene 1

Gene

interleukin 9 receptor

Gene

long intergenic non-protein coding RNA 1139

Gene

long intergenic non-protein coding RNA 865

  • Gene

    small nucleolar RNA host gene 4


  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    small nucleolar RNA host gene 12


  • Gene

    USP2 antisense RNA 1


  • Gene

    dual specificity phosphatase 13A


  • Gene

    ZBED5 antisense RNA 1


  • Gene

    RRN3 pseudogene 1


  • Gene

    interleukin 9 receptor


  • Gene

    long intergenic non-protein coding RNA 1139


  • Gene

    long intergenic non-protein coding RNA 865

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.